G1 Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Location
700 Park Offices Drive, Suite 200, Research Triangle Park, NC

There are no Buy or Sell transactions made by insiders since 12/7/2024

G1 Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Mark A. Velleca Director $341K Aug 8, 2023
Jennifer K. Moses Cfo $170K Jan 3, 2023
James S. Hanson General Counsel $121K Jan 3, 2023
Willie A. Deese Director $42.3K Jun 23, 2022
Seth Rudnick Director $28.4K Jun 29, 2021
Jacks Lee Director $0 Sep 18, 2024
Glenn P. Muir Director $0 Sep 18, 2024
Mark Avagliano Chief Business Officer $0 Sep 18, 2024
Andrew Perry Chief Commercial Officer $0 Sep 18, 2024
John E. Bailey President and CEO, Director $0 Sep 18, 2024
Garry A. Nicholson Director $0 Sep 18, 2024
Rajesh Malik Chief Medical Officer $0 Sep 18, 2024
Monica Thomas Chief Legal & People Officer $0 Sep 18, 2024
Terry L. Murdock Chief Operating Officer $0 Sep 18, 2024
Alicia Secor Director $0 Sep 18, 2024
Cynthia Louise Flowers Director $0 Sep 18, 2024
W. Umstead John Chief Financial Officer $0 Sep 18, 2024
Norman Sharpless Director $0 Sep 18, 2024

Recent Insider Transactions by Companies or Individuals for G1 Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.